Effects of dopaminergic agonists and antagonists on cerebellar guanosine-3',5'-monophosphate (cGMP).
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D001058:Apomorphine / Q000037:antagonists & inhibitors; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism*; D006152:Cyclic GMP / Q000378:metabolism*; D004298:Dopamine / Q000502:physiology*; D018492:Dopamine Antagonists; D066298:In Vitro Techniques; D051381:Rats
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D006152:Cyclic GMP; D001058:Apomorphine; D004298:Dopamine